Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function

This publication has 70 references indexed in Scilit:

• Efficacy and Safety of Incretin Therapy in Type 2 Diabetes
  JAMA, 2007
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
  Published by Elsevier ,2006
• T-cell activation via CD26 and caveolin-1 in rheumatoid synovium
  Modern Rheumatology, 2006
• Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2001
• Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage
  The Journal of Experimental Medicine, 1997
• Cell surface characterization of T lymphocytes and allergen-specific T cell clones: Correlation of CD26 expression with T H1 subsets
  Journal of Allergy and Clinical Immunology, 1997
• Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV
  International Journal of Immunopharmacology, 1997
• CD26: a surface protease involved in T-cell activation
  Immunology Today, 1994
• In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple Sclerosis
  New England Journal of Medicine, 1985
• THE FINE STRUCTURE OF THE GALL BLADDER EPITHELIUM OF THE MOUSE
  The Journal of cell biology, 1955